Register for the Glasgow Jalview workshop


Jalview is free to end-users because of support from the UK's BBSRC and The Wellcome Trust

If you would like to see Jalview continue to be available then please take a few minutes to write us a support letter saying how you use Jalview in your research/teaching.

Write as a PDF including your institution's heading and send to:
support_jalview@bartongroup.org by Friday 19th October 2018.

Thank you all those who have already written such nice letters!

Posted On: 
07-09-2016

Protein, RNA and DNA multiple sequence alignment and functional analysis workshop using Jalview

On 9.15am - 5.00pm Friday 14th October

At Strathclyde Institute of Pharmacy and Biomedical Sciences, Room CV309b, Coville Building, 16 Richmond Street, Glasgow G1 1XQ

This one day computer based hands-on training course is designed for life sciences graduate students and researcher scientists who works with proteins, RNA and DNA sequence data. The course will involve presentations, hands-on exercises and demonstrations. Plus, there are opportunities during the day to discuss your own analysis problems with the Jalview developers. Participants are given a Jalview training manual.

The course is suitable for both Jalview novices and experienced users who would like to learn more about Jalview's capabilities.

Tea, coffee and lunch provided.

Course Aims: to provide training in how to use Jalview multiple sequence alignment visualisation program to visualise proteins, RNA and DNA data.

Learning topics:

  • Introducing Jalview and its capabilities
  • Launching Jalview from a web browser
  • Loading, editing and saving sequences and alignments
  • Selecting and creating groups
  • Colouring sequences and figure generation
  • Undertaking multiple sequence alignment,
  • Viewing annotation and features
  • PCA and tree analysis
  • Working with 3D structures
  • Protein prediction analysis
  • Working with RNA sequences and integrating cDNA and protein analysis

Register:                CLOSED

Numbers are limited and will be allocated on a first come-first serve basis.